EDWARDSVILLE, Ill., Aug. 14,
2024 /PRNewswire/ -- Flint Cooper is proud to
announce that Alex Parker has been
appointed to the Leadership Development Committee (LDC) for the
Suboxone (Buprenorphine/Naloxone) Film Products Liability
Litigation, MDL No. 3092. This appointment by the United States District Court for the
Northern District of Ohio, Eastern
Division, underscores Parker's commitment to mass tort litigation
and his potential as a future leader in this field.
"Alex Parker's appointment to the
Leadership Development Committee is a testament to his dedication,"
stated Ethan Flint, co-managing
member of Flint Cooper. "This role will provide him with invaluable
experience, further enhancing our firm's ability to advocate for
our clients."
The LDC was established to mentor emerging attorneys and foster
their professional growth through substantive work and constructive
supervision. The Court aims to cultivate the next generation of MDL
leaders by allowing less experienced attorneys to collaborate
closely with seasoned members of the Plaintiffs' Leadership
Committee.
As an LDC member, Parker will work directly under the guidance
of the Executive Committee co-leads. The role requires a deep
understanding of the litigation, a commitment to excellence and the
ability to collaborate effectively. Parker's appointment is
personal and non-transferable, reflecting his dedication to this
litigation.
Trent Miracle, managing member of
Flint Cooper's mass torts practice and co-lead counsel in the
Suboxone MDL, also expressed support: "Alex's role on the LDC is
well-deserved. His understanding of the complexities of this case
makes him a perfect fit for this committee."
The LDC selection process was rigorous, involving interviews and
evaluations by the LDC chair and co-leads, who assessed each
applicant's background, skills and commitment to plaintiffs'
representation in mass tort MDLs. Parker was selected based on his
collaborative skills, personal interest in the litigation and
dedication to the case's long-term success.
"I am honored to be appointed to the Leadership Development
Committee and eager to contribute to the important work we are
doing for our clients and all affected parties," remarked
Parker.
Flint Cooper congratulates Alex
Parker on this achievement and looks forward to his
continued contributions to the firm and its clients in the Suboxone
MDL.
ABOUT FLINT COOPER
Flint Cooper (FlintCooper.com) is a
preeminent litigation firm managing a diverse portfolio of
multibillion-dollar cases. Co-led by founding members Ethan Flint and Jeff
Cooper, both renowned for their work on asbestos-related
cases and Fifth Amendment federal takings cases, Flint Cooper
boasts a national presence and the ability to file and try cases
anywhere. With offices in Edwardsville,
Illinois; Paducah,
Kentucky; and Dallas,
Texas, Flint Cooper handles catastrophic personal injury and
product liability cases, litigates cases involving terminal
illnesses and represents the largest contingent of plaintiffs with
claims against the federal government of any single firm in the
country.
MEDIA CONTACT
Fred
Licon
Fred@FlintCooper.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/flint-cooper-attorney-alex-parker-appointed-to-leadership-development-committee-in-suboxone-multidistrict-litigation-302222625.html
SOURCE Flint Cooper